Literature DB >> 22521747

Increasing the risk of late rectal bleeding after high-dose radiotherapy for prostate cancer: the case of previous abdominal surgery. Results from a prospective trial.

Riccardo Valdagni1, Vittorio Vavassori, Tiziana Rancati, Gianni Fellin, Micaela Baccolini, Carla Bianchi, Emanuela Cagna, Pietro Gabriele, Floranna Mauro, Loris Menegotti, Angelo Filippo Monti, Michele Stasi, Claudio Fiorino.   

Abstract

PURPOSE: To evaluate and discuss the role of specific types of abdominal surgery (SURG) before radical radiation therapy as a risk factor for late rectal toxicity in prostate cancer patients.
METHODS: Results concerning questionnaire-based scored late bleeding and faecal incontinence in 718 patients with a complete follow-up of 36 months were analysed, focusing on the impact of specific pre-radiotherapy abdominal/pelvic surgery procedures. Patients were accrued in the prospective study AIROPROS 0102. Different types of surgery (rectum-sigma resection, kidney resection, cholecystectomy or appendectomy) were considered as covariates together with a number of different parameters previously found to be predictive of late toxicity and including clinical as well as dosimetric parameters. Univariate (UVA) and multivariate (MVA) logistic analyses were carried out.
RESULTS: In total 69/718 patients were previously submitted to one or more surgical procedures, mostly cholecystectomy (n=21) and appendectomy (n=27). Actuarial incidences of G2-G3 and G3 bleeding were 52 (7.2%) and 24 (3.3%) respectively; 19 (2.6%) chronic incontinence events were registered. Cholecystectomy was found to be highly correlated with late rectal bleeding at UVA: OR=4.3 and p=0.006 for G2-G3 and OR=5.4 and p=0.01 for G3. Considering MVA (including dosimetric and clinical factors), G2-G3 bleeding was significantly correlated to cholecystectomy (OR=6.5, p=0.002), V75 Gy (OR=1.074, p=0.003) and secondarily with appendectomy (OR=2.7, p=0.10), presence of acute radioinduced rectal bleeding (OR=1.70, p=0.21) and androgen deprivation (OR=0.67, p=0.25). Appendectomy (OR=5.9, p=0.004) and cholecystectomy (OR=5.5, p=0.016) were very strong predictors of G3 bleeding with V75 Gy playing a less significant role (OR=1.037, p=0.26). Conversely, no specific surgery was correlated with actuarial or chronic incontinence.
CONCLUSIONS: This analysis highlights previous SURG as the best predictor of late rectal bleeding. Among the different types of abdominal surgery, cholecystectomy and appendectomy play the major role, especially for severe late bleeding.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22521747     DOI: 10.1016/j.radonc.2012.03.012

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  12 in total

Review 1.  Inclusion of dosimetric data as covariates in toxicity-related radiogenomic studies : A systematic review.

Authors:  Noorazrul Yahya; Xin-Jane Chua; Hanani A Manan; Fuad Ismail
Journal:  Strahlenther Onkol       Date:  2018-05-17       Impact factor: 3.621

2.  Planning study to compare dynamic and rapid arc techniques for postprostatectomy radiotherapy of prostate cancer.

Authors:  R Cambria; F Cattani; B A Jereczek-Fossa; F Pansini; D Ciardo; S Vigorito; S Russo; D Zerini; L Cozzi; R Orecchia
Journal:  Strahlenther Onkol       Date:  2014-02-21       Impact factor: 3.621

3.  Intensity-modulated radiation therapy for prostate cancer after rectal surgery: a single hospital long-term safety analysis.

Authors:  Shuang Zhang; Kiyonao Nakamura; Rihito Aizawa; Shusuke Akamatsu; Takashi Mizowaki
Journal:  Int J Clin Oncol       Date:  2022-02-05       Impact factor: 3.402

Review 4.  Reducing rectal injury during external beam radiotherapy for prostate cancer.

Authors:  Riccardo Valdagni; Tiziana Rancati
Journal:  Nat Rev Urol       Date:  2013-05-14       Impact factor: 14.432

5.  Predictive Factors of Late-onset Rectal Mucosal Changes After Radiotherapy of Prostate Cancer.

Authors:  Edy Ippolito; Alessandra Guido; Gabriella Macchia; Francesco Deodato; Lucia Giaccherini; Andrea Farioli; Alessandra Arcelli; Dajana Cuicchi; Leonardo Frazzoni; Savino Cilla; Milly Buwenge; Giovanna Mantini; Anna R Alitto; Marianna Nuzzo; Vincenzo Valentini; Marcello Ingrosso; Alessio G Morganti; Lorenzo Fuccio
Journal:  In Vivo       Date:  2017 Sep-Oct       Impact factor: 2.155

6.  Multivariate normal tissue complication probability modeling of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer.

Authors:  Laura Cella; Vittoria D'Avino; Raffaele Liuzzi; Manuel Conson; Francesca Doria; Adriana Faiella; Filomena Loffredo; Marco Salvatore; Roberto Pacelli
Journal:  Radiat Oncol       Date:  2013-09-23       Impact factor: 3.481

7.  Evaluation of Mediators Associated with the Inflammatory Response in Prostate Cancer Patients Undergoing Radiotherapy.

Authors:  Nice Bedini; Alessandro Cicchetti; Federica Palorini; Tiziana Magnani; Valentina Zuco; Marzia Pennati; Elisa Campi; Paola Allavena; Samantha Pesce; Sergio Villa; Barbara Avuzzi; Sara Morlino; Maria Emanuela Visentin; Nadia Zaffaroni; Tiziana Rancati; Riccardo Valdagni
Journal:  Dis Markers       Date:  2018-02-25       Impact factor: 3.434

8.  Late Gastrointestinal Tolerance After Prostate Radiotherapy: Is the Anal Canal the Culprit? A Narrative Critical Review.

Authors:  Paul Sargos; Mame Daro Faye; Manon Bacci; Stéphane Supiot; Igor Latorzeff; David Azria; Tamim M Niazi; Te Vuong; Véronique Vendrely; Renaud de Crevoisier
Journal:  Front Oncol       Date:  2021-06-16       Impact factor: 6.244

9.  Preliminary analysis of risk factors for late rectal toxicity after helical tomotherapy for prostate cancer.

Authors:  Natsuo Tomita; Norihito Soga; Yuji Ogura; Norio Hayashi; Hidetoshi Shimizu; Takashi Kubota; Junji Ito; Kimiko Hirata; Yukihiko Ohshima; Hiroyuki Tachibana; Takeshi Kodaira
Journal:  J Radiat Res       Date:  2013-03-22       Impact factor: 2.724

Review 10.  Transitioning from conventional radiotherapy to intensity-modulated radiotherapy for localized prostate cancer: changing focus from rectal bleeding to detailed quality of life analysis.

Authors:  Hideya Yamazaki; Satoaki Nakamura; Takuya Nishimura; Ken Yoshida; Yasuo Yoshioka; Masahiko Koizumi; Kazuhiko Ogawa
Journal:  J Radiat Res       Date:  2014-09-08       Impact factor: 2.724

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.